Nanotechnology for Cancer Imaging: Advances, Challenges, and Clinical Opportunities

Area of Science:

• Biomedical Engineering
• Oncology
• Medical Imaging

Background:

• Nanoparticles (NPs) show potential in cancer diagnostics, therapeutics, and treatment management.
• NPs can enhance imaging contrast, sensitivity, and specificity for in vivo molecular and cellular imaging.
• Current oncologic imaging faces limitations that NP-based agents could address.

Purpose of the Study:

• To review promising nanoparticle-enabled imaging techniques for cancer.
• To highlight how these techniques can overcome current clinical cancer imaging limitations.
• To inspire clinical translation and improve patient care in oncology.

Main Methods:

• Review of preclinical and clinical advancements in NP-based imaging.
• Analysis of NP applications in cancer diagnostics and treatment monitoring.
• Discussion of NP-enabled optical imaging and its role in detecting metastases.

Main Results:

• Nanoparticle imaging agents offer improved signal sensitivity and specificity.
• NP-based techniques show potential for enhanced cancer diagnostics and surgical guidance.
• Despite advancements, clinical translation of NP imaging agents remains limited.

Conclusions:

• Nanoparticle imaging holds significant promise for improving cancer care through enhanced diagnostics and treatment monitoring.
• Further research and development are crucial for successful clinical translation of NP-based imaging agents.
• NP-enabled imaging can provide unique in vivo tools to address biologic questions and improve patient outcomes in oncology.